Asparaginase
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6199 publications
Aspartic Acid Catalyzed by Asparaginase Provides Rice with Broad-Spectrum Resistance.
Journal: Journal of agricultural and food chemistry
Published: July 23, 2026
Asparaginase-Based Treatment Modifications and their effect on Pediatric Acute Lymphoblastic Leukemia Outcomes: A Single-Center Experience.
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: July 16, 2026
Acute Pancreatitis Complicating L-asparaginase Therapy in Pediatric Oncology: A Case Report.
Journal: Cureus
Published: June 18, 2026
Salmonella Typhi asparaginase-dependent activation of GCN2 promotes bacterial killing in murine macrophages.
Journal: Infection and immunity
Published: June 15, 2026
Real-World Outcomes of Frontline Multimodal Treatment Strategies for Localized Extranodal NK/T-Cell Lymphoma, Nasal Type: A Single-Center Vietnamese Cohort Study.
Journal: Current oncology (Toronto, Ont.)
Published: June 13, 2026
Occurrence of acrylamide and 4-methylimidazole in roasted and ground coffee and the effect of L-asparaginase treatment of green coffee on their levels.
Journal: Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment
Published: June 05, 2026
Therapeutic recombinant L-asparaginases: a comprehensive review and way forward.
Journal: Critical reviews in biotechnology
Published: June 05, 2026
Analysis of Clinical Characteristics and Prognosis of Asparaginase-Associated Pancreatitis in Children with Acute Lymphoblastic Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 02, 2026
Fusion Protein Technology to Enhance Pharmacological Properties of L-Asparaginases.
Journal: Biomolecules
Published: May 25, 2026
Drug-associated acute pancreatitis in paediatric versus adult reports: a disproportionality analysis using FAERS.
Journal: European journal of pediatrics
Published: May 22, 2026
Economic burden associated with switching from frontline pegaspargase or calaspargase pegol to second-line recombinant Erwinia in pediatrics and adolescents/young adults with acute lymphoblastic leukemia.
Journal: Journal of medical economics
Published: May 21, 2026
Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 18, 2026
Last Updated: 09/26/2026